Aventis Appeals Merger Regulatory Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Aventis will go to court in an effort to reverse regulatory approval of a hostile take-over bid by Sanofi-Synthelabo, the company announced Feb. 13